Dihydromyricetin Ameliorates Cardiac Ischemia/Reperfusion Injury through Sirt3 Activation
DHM alleviated MI/R injury. (a, b) Lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB). (c) The infarct area in each group. (d, e) Quantitative analysis of infarct area and AAR/LV. Mean ± SEM (n=12), P<0.05 vs WT+sham group; #P<0.05 vs Sirt3−/− + sham group; §P < 0.05 vs MI/R group; P<0.05 vs Sirt3−/−+MI/R group; &P<0.05 vs MI/R +DHM group.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.